Unmasking the FDA’s Policy on Cloned Food
By Osagie K. Obasogie and Pete Shanks,
The Cutting Edge
| 08. 12. 2007
The FDA is still considering whether to allow meat and milk from cloned animals into America's food chain, without so much as a warning label. Polls show that Americans oppose cloned foods 3 to 1, and the livestock and dairy industries have repeatedly said that cloned hotdogs and milkshakes make little business sense. Neverthless, the push for cloned livestock has been insistent for years.
In 2003, approval was said to be six months away; that didn't happen, presumably because of fears of public outrage, but the public relations campaign continued. At the very end of 2006, a long-awaited draft "Risk Assessment" was published, inspiring a flurry of ill-informed puff pieces intended to legitimize the technology. That failed: the FDA received over 100,000 public comments, overwhelmingly opposed to food from cloned animals.
Officials then paused to consider their final decision. Some reports say that FDA approval will come later this year. Others suggest that it may take two years. The mainstream media seems to accept that it's only a matter of time, no matter what the public wants - and no...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...